Regular Use of VKA Prior to COVID-19 Associated with Lower 7-Day Survival in Hospitalized Frail Elderly COVID-19 Patients: The GERIA-COVID Cohort Study.
Pierre MénagerOlivier BrièreJennifer GautierJérémie RiouGuillaume SaccoAntoine BrangierCedric AnnweilerOn Behalf Of The Geria-Covid Study GroupPublished in: Nutrients (2020)
Regular use of VKA was associated with increased mortality at day 7 in hospitalized frail elderly patients with COVID-19.